20:38 , Dec 16, 2016 |  BC Week In Review  |  Financial News

GI Dynamics completes private placement

GI Dynamics raised A$1.5 million ($1.1 million) through the sale of 69.9 million CHESS Depositary Interests (CDI) at A$0.02 in a private placement with sophisticated and professional investors and existing investors. Each CDI represents a...
08:00 , Dec 14, 2015 |  BC Week In Review  |  Financial News

Starpharma completes private placement

Starpharma Holdings Ltd. (ASX:SPL; OTCQX:SPHRY), Melbourne, Australia   Business: Infectious   Date completed: 2015-12-09   Type: Private placement   Raised: A$32 million ($23.4 million)   Price: A$0.73   Shares outstanding prior: 320.6 million   Investor:...
07:00 , Oct 6, 2014 |  BC Week In Review  |  Financial News

Starpharma completes private placement

Starpharma Holdings Ltd. (ASX:SPL; OTCQX:SPHRY), Melbourne, Australia   Business: Infectious   Date completed: 2014-09-22   Type: Private placement   Raised: A$18 million ($15.7 million)   Shares: 27.7 million   Price: A$0.65   Shares after offering:...
07:00 , Jul 21, 2014 |  BC Week In Review  |  Financial News

Phosphagenics completes private placement

Phosphagenics Ltd. (ASX:POH; OTCQX:PPGNY), Melbourne, Australia   Business: Drug delivery, Neurology   Date completed: 2014-07-11   Type: Private placement   Raised: A$12.2 million ($11.5 million)   Shares: 153 million   Price: A$0.08   Shares after...
02:12 , Mar 5, 2013 |  BC Extra  |  Financial News

Bionomics proposes A$16.4 million rights offer

Bionomics Ltd. (ASX:BNO; OTCBB:BMICY) said it plans to raise up to A$16.4 million ($16.6 million) through the sale of up to 45.6 million shares at A$0.36 in a rights offering. Existing shareholders are eligible to...
07:00 , Aug 8, 2011 |  BioCentury  |  Finance

Firmer footing

Firmer footing Pain play QRxPharma Ltd. (ASX:QRX; OTCQX:QRXPY) raised A$25 million ($27 million) last month in a private placement designed to strengthen its financial footing for partnership discussions for its lead program in pain. The...
07:00 , Aug 1, 2011 |  BC Week In Review  |  Financial News

QRxPharma completes private placement

QRxPharma Ltd. (ASX:QRX; OTCQX:QRXPY), Sydney, Australia   Business: Neurology   Date completed: 7/22/11   Type: Private placement   Raised: A$25 million (US$27 million)   Shares: 17.2 million   Price: A$1.45   Shares after offering: 143.1...
07:00 , Aug 1, 2011 |  BC Week In Review  |  Financial News

QRxPharma proposes rights offering

QRxPharma Ltd. (ASX:QRX; OTCQX:QRXPY), Sydney, Australia   Business: Neurology   Date announced: 7/20/11   Type: Rights offering   To be raised: Up to A$10.4 million (US$11.2 million)   Shares: 7.2 million   Price: A$1.45  ...
23:39 , Jul 25, 2011 |  BC Extra  |  Financial News

QRxPharma raises $27 million

QRxPharma Ltd. (ASX:QRX; OTCQX:QRXPY) raised A$25 million ($27 million) through the sale of 17.2 million shares at A$1.45 in a private placement. The price is a 10% discount to QRxPharma's close of A$1.61 on July...
08:00 , Jan 16, 2006 |  BC Week In Review  |  Company News

pSivida Ltd. board of directors update

pSivida Ltd. (ASX:PSD; PSDV), Perth, Australia   Business: Drug delivery, Diagnostic, Dermatology   Appointed: Heather Zampatti, national head of wealth management at Bell Potter Securities Ltd.  ...